{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T08:47:44Z","timestamp":1785833264140,"version":"3.56.0"},"reference-count":46,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Introduction: Cardiovascular risk prediction remains challenging, particularly in patients with intermediate risk, mixed dyslipidemia, elevated lipoprotein(a), or variable lipid profiles. Conventional risk calculators may not fully capture nonlinear relationships among lipid, clinical, imaging, and longitudinal data. Objectives: This narrative review summarizes evidence on artificial intelligence (AI)-based cardiovascular risk assessment, focusing on lipid profile-based and multimodal models incorporating lipid-related variables. Methods: PubMed\/MEDLINE, Scopus, and Google Scholar were searched for English-language articles published up to January 2026. Original studies, reviews, and relevant clinical guidelines addressing AI-based cardiovascular risk models, lipid-related predictors, and clinically applicable approaches were considered. Results: Lipid profile-based AI models may identify lipid phenotypes and lipid-related patterns associated with increased cardiovascular risk, while multimodal models have shown improved performance in selected datasets. However, the reviewed studies address heterogeneous tasks, including phenotype classification, cardiovascular event prediction, mortality prediction, patient trajectory modeling, and absolute risk estimation. Most evidence remains retrospective, with limited external validation, calibration assessment, and clinical utility data. Conclusions: AI-based models may support cardiovascular risk assessment, but routine implementation requires prospective validation, standardized evaluation, calibration, explainability, and clinical impact studies.<\/jats:p>","DOI":"10.3390\/jcm15156053","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T08:02:19Z","timestamp":1785830539000},"page":"6053","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Artificial Intelligence in Cardiovascular Risk Prediction: An Up-to-Date Narrative Review on the Emerging Role of Lipid Profile-Based Models"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-6627-8295","authenticated-orcid":false,"given":"Patrycja","family":"Pi\u0142at","sequence":"first","affiliation":[{"name":"3rd Department of Cardiology, Silesian Center for Heart Disease in Zabrze, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, 41-800 Zabrze, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4236-2141","authenticated-orcid":false,"given":"Rados\u0142aw","family":"Dutczak","sequence":"additional","affiliation":[{"name":"Department of Physiology, Faculty of Medical Sciences in Katowice, Medical University of Silesia in Katowice, 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariusz","family":"G\u0105sior","sequence":"additional","affiliation":[{"name":"3rd Department of Cardiology, Silesian Center for Heart Disease in Zabrze, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, 41-800 Zabrze, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Przemys\u0142aw","family":"Trzeciak","sequence":"additional","affiliation":[{"name":"3rd Department of Cardiology, Silesian Center for Heart Disease in Zabrze, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, 41-800 Zabrze, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Salari, N., Morddarvanjoghi, F., Abdolmaleki, A., Rasoulpoor, S., Khaleghi, A.A., Hezarkhani, L.A., Shohaimi, S., and Mohammadi, M. (2023). The global prevalence of myocardial infarction: A systematic review and meta-analysis. BMC Cardiovasc. Disord., 23.","DOI":"10.1186\/s12872-023-03231-w"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"ehae666.1657","DOI":"10.1093\/eurheartj\/ehae666.1657","article-title":"Symptoms and ASCVD score fail to identify majority of the patients at risk of first myocardial infarction","volume":"45","author":"Mueller","year":"2024","journal-title":"Eur. Heart J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12944-025-02471-3","article-title":"Novel lipid profiles and atherosclerotic cardiovascular disease risk: Insights from a latent profile analysis","volume":"24","author":"Wan","year":"2025","journal-title":"Lipids Health Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1161\/CIRCULATIONAHA.124.069556","article-title":"Independence of Lipoprotein(a) and Low-Density Lipoprotein Cholesterol\u2013Mediated Cardiovascular Risk: A Participant-Level Meta-Analysis","volume":"151","author":"Bhatia","year":"2024","journal-title":"Circulation"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Haegele, M., Djurdjevic, A., Jordan, F., Liu, Y.-C., Mildner, L., Frey, S., Strebel, I., Clerc, O., Burkard, T., and Pfister, O. (2022). Achievement of Low-Density Lipoprotein Cholesterol Targets in Cardiac Rehabilitation: Impact of the 2019 ESC\/EAS Dyslipidaemia Guidelines. J. Clin. Med., 11.","DOI":"10.3390\/jcm11237057"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1440-1681.2010.05380.x","article-title":"Anti-oxidant properties of high-density lipoprotein and atherosclerosis","volume":"37","author":"Podrez","year":"2010","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/eurheartj\/ehr112","article-title":"Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: Evidence and guidance for management","volume":"32","author":"Chapman","year":"2011","journal-title":"Eur. Heart J."},{"key":"ref_8","unstructured":"(2021). SCORE2 working group and ESC Cardiovascular risk collaboration. SCORE2 risk prediction algorithms: New models to estimate 10-year risk of cardiovascular disease in Europe. Eur. Heart J., 42, 2439\u20132454."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1161\/CIRCULATIONAHA.123.067626","article-title":"Development and Validation of the American Heart Association\u2019s PREVENT Equations","volume":"149","author":"Khan","year":"2024","journal-title":"Circulation"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1161\/01.cir.0000437741.48606.98","article-title":"2013 ACC\/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Goff","year":"2014","journal-title":"Circulation"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jacc.2024.05.003","article-title":"Transforming cardiovascular care with artificial intelligence: From discovery to practice: JACC state-of-the-art review","volume":"84","author":"Kheraa","year":"2024","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.5114\/amsad\/220788","article-title":"Artificial Intelligence in Preventive Care in Primary Health Care Settings: A Scoping Review","volume":"11","author":"Katsakiori","year":"2026","journal-title":"Arch. Med. Sci. Atheroscler. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s11883-024-01210-w","article-title":"Artificial intelligence in cardiovascular disease prevention: Is it ready for prime time?","volume":"26","author":"Parsa","year":"2024","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"911","DOI":"10.21037\/cdt.2020.03.09","article-title":"Artificial intelligence in personalized cardiovascular medicine and cardiovascular imaging","volume":"11","author":"Haq","year":"2020","journal-title":"Cardiovasc. Diagn. Ther."},{"key":"ref_16","first-page":"167","article-title":"Machine Learning & Deep Learning Tools in Pharmaceutical Sciences: A Comprehensive Review","volume":"3","author":"Javid","year":"2025","journal-title":"Intell. Pharm."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12944-021-01475-z","article-title":"Risk stratification of ST-segment elevation myocardial infarction (STEMI) patients using machine learning based on lipid profiles","volume":"20","author":"Xue","year":"2021","journal-title":"Lipids Health Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s13755-024-00310-w","article-title":"Machine-learning-based prediction of cardiovascular events for hyperlipidemia population with lipid variability and remnant cholesterol as biomarkers","volume":"12","author":"Du","year":"2024","journal-title":"Health Inf. Sci. Syst."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s42269-024-01295-y","article-title":"Machine learning algorithms for predictive modeling of dyslipidemia-associated cardiovascular disease risk in pregnancy: A comparison of boosting, random forest, and decision tree regression","volume":"49","author":"Sadiq","year":"2025","journal-title":"Bull. Natl. Res. Cent."},{"key":"ref_20","unstructured":"Islam, S.M.S., Abrar, M., Tegegne, T., Loranjo, L., Karmakar, C., Awal, M.A., Hossain, M.S., Kabir, M.A., Mahmud, M., and Khosravi, A. (2024). Machine Learning Models for the Identification of Cardiovascular Diseases Using UK Biobank Data. arXiv."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Bagheri, A., Groenhof, T.K.J., Veldhuis, W.B., de Jong, P.A., Asselbergs, F.W., and Oberski, D.L. (2020). Multimodal Learning for Cardiovascular Risk Prediction using EHR Data. arXiv.","DOI":"10.1145\/3388440.3414924"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Kwon, J.-M., Jeon, K.-H., Kim, H.M., Kim, M.J., Lim, S., Kim, K.-H., Song, P.S., Park, J., Choi, R.K., and Oh, B.-H. (2019). Deep-learning-based risk stratification for mortality of patients with acute myocardial infarction. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0224502"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41746-020-00331-1","article-title":"Machine learning and atherosclerotic cardiovascular disease risk prediction in a multi-ethnic population","volume":"3","author":"Ward","year":"2020","journal-title":"npj Digit. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"100873","DOI":"10.1016\/j.landig.2025.03.005","article-title":"Refined selection of individuals for preventive cardiovascular disease treatment with a transformer-based risk model","volume":"7","author":"Rao","year":"2025","journal-title":"Lancet Digit. Health"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41746-025-02296-5","article-title":"A transformer-based survival model for prediction of all-cause mortality in patients with heart failure: A multi-cohort study","volume":"9","author":"Rao","year":"2026","journal-title":"npj Digit. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/s41746-024-01235-0","article-title":"Zero Shot Health Trajectory Prediction Using Transformer","volume":"7","author":"Renc","year":"2024","journal-title":"NPJ Digit. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e791","DOI":"10.1016\/S2589-7500(24)00172-9","article-title":"Artificial intelligence-enabled electrocardiogram for mortality and cardiovascular risk estimation: A model development and validation study","volume":"6","author":"Sau","year":"2024","journal-title":"Lancet Digit. Health"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Rezk, N.G., Alshathri, S., Sayed, A., El-Din Hemdan, E., and El-Behery, H. (2024). XAI-Augmented Voting Ensemble Models for Heart Disease Prediction: A SHAP and LIME-Based Approach. Bioengineering, 11.","DOI":"10.3390\/bioengineering11101016"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Uddin, S., Khan, A., Hossain, M.E., and Moni, M.A. (2019). Comparing different supervised machine learning algorithms for disease prediction. BMC Med. Inform. Decis. Mak., 19.","DOI":"10.1186\/s12911-019-1004-8"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"55","DOI":"10.7326\/M14-0697","article-title":"Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): The TRIPOD Statement","volume":"162","author":"Collins","year":"2015","journal-title":"Ann. Intern Med."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Naderian, S., Nikniaz, Z., Abbasalizad Farhangi, M., Nikniaz, L., Sama-Soltani, T., and Rostami, P. (2024). Predicting dyslipidemia incidence: Unleashing machine learning algorithms on Lifestyle Promotion Project data. BMC Public Health, 24.","DOI":"10.1186\/s12889-024-19261-8"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1016\/j.jacc.2018.09.042","article-title":"Coronary Microvascular Disease Pathogenic Mechanisms and Therapeutic Options: JACC State-of-the-Art Review","volume":"72","author":"Taqueti","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Rojek, I., Kotlarz, P., Kozielski, M., Jagodzi\u0144ski, M., and Kr\u00f3likowski, Z. (2024). Development of AI-Based Prediction of Heart Attack Risk as an Element of Preventive Medicine. Electronics, 13.","DOI":"10.3390\/electronics13020272"},{"key":"ref_34","unstructured":"Maimon, O., and Rokach, L. (2008). Introduction to decision trees. Data Mining with Decision Trees: Theory and Applications, World Scientific Publishing."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"110121","DOI":"10.1016\/j.chaos.2020.110121","article-title":"Deep learning methods for forecasting COVID-19 time-series data: A comparative study","volume":"140","author":"Zeroual","year":"2020","journal-title":"Chaos Solitons Fractals"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Krittanawong, C., Omar, A.M.S., Narula, S., Sengupta, P.P., Glicksberg, B.S., Narula, J., and Argulian, E. (2023). Deep Learning for Echocardiography: Introduction for Clinicians and Future Vision: State-of-the-Art Review. Life, 13.","DOI":"10.3390\/life13041029"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s10916-016-0432-6","article-title":"Diagnosis of Acute Coronary Syndrome with a Support Vector Machine","volume":"40","author":"Berikol","year":"2016","journal-title":"J. Med. Syst."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e26772","DOI":"10.1016\/j.heliyon.2024.e26772","article-title":"Multimodal Risk Prediction with Physiological Signals, Medical Images and Clinical Notes","volume":"10","author":"Wang","year":"2024","journal-title":"Heliyon"},{"key":"ref_39","unstructured":"U.S. Food and Drug Administration (2026, March 11). AI-Enabled Medical Devices, Available online: https:\/\/www.fda.gov\/medical-devices\/software-medical-device-samd\/artificial-intelligence-enabled-medical-devices?utm_medium=email&utm_source=govdeliveryal."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"109370","DOI":"10.1016\/j.compeleceng.2024.109370","article-title":"A review of Explainable Artificial Intelligence in healthcare","volume":"118","author":"Sadeghi","year":"2024","journal-title":"Comput. Electr. Eng."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Antoniadi, A.M., Du, Y., Guendouz, Y., Wei, L., Mazo, C., Becker, B.A., and Mooney, C. (2021). Current Challenges and Future Opportunities for XAI in Machine Learning-Based Clinical Decision Support Systems: A Systematic Review. Appl. Sci., 11.","DOI":"10.3390\/app11115088"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2400304","DOI":"10.1002\/aisy.202400304","article-title":"A Perspective on Explainable Artificial Intelligence Methods: SHAP and LIME","volume":"7","author":"Salih","year":"2025","journal-title":"Adv. Intell. Syst."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Leivaditis, V., Gottardi, R., Maniatopoulos, A.A., Mulita, F., Pylarinou, C., Papadoulas, S., Nikolakopoulos, K., Panagiotopoulos, I., Koletsis, E., and Dahm, M. (2026). Twin Transformation in Cardiothoracic Surgery: The Convergence of Digital Innovation and Sustainability. J. Cardiovasc. Dev. Dis., 13.","DOI":"10.3390\/jcdd13030122"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"M\u0142ynarska, E., Bojdo, K., Frankenstein, H., Kustosik, N., Mstowska, W., Przybylak, A., Rysz, J., and Franczyk, B. (2025). Nanotechnology and Artificial Intelligence in Dyslipidemia Management\u2014Cardiovascular Disease: Advances, Challenges, and Future Perspectives. J. Clin. Med., 14.","DOI":"10.3390\/jcm14030887"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Escobar-Cervantes, C., Salda\u00f1a-Garc\u00eda, J., Torremocha-L\u00f3pez, A., Contreras-Lorenzo, C., Lara-Garc\u00eda, A., Canales-Mu\u00f1oz, L., Mart\u00ednez-Gonz\u00e1lez, R., Vila-Garc\u00eda, J., and Banach, M. (2025). Integrating New Technologies in Lipidology: A Comprehensive Review. J. Clin. Med., 14.","DOI":"10.3390\/jcm14144984"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1097\/HJH.0000000000003807","article-title":"Asymptomatic hyperuricemia: To treat or not a threat? A clinical and evidence-based approach to the management of hyperuricemia in the context of cardiovascular diseases","volume":"42","author":"Fiori","year":"2024","journal-title":"J. Hypertens."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/15\/6053\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T08:37:30Z","timestamp":1785832650000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/15\/6053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":46,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["jcm15156053"],"URL":"https:\/\/doi.org\/10.3390\/jcm15156053","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]}}}